Effects of high cell density on growth-associated monoclonal antibody production by hybridoma T0405 cells immobilized in macroporous cellulose carriers

Relationship between monoclonal antibody (MAb) productivity and growth rate, and effects of high cell density on MAb production of hybridoma T0405 cells immobilized in macroporous cellulose carriers were investigated in continuous and batch cultures. The results showing, that the specific MAb production rate increased with increasing specific growth rate in both suspended and immobilized continuous cultures indicate a positively growth-associated relationship between MAb productivity and growth rate. Moreover, the specific production rate was higher in the immobilized cell culture than that in suspended one at all dilution rates. In order to clarify these phenomena, MAb mRNA expression and cell cycle distribution were investigated in batch cultures with immobilized cells and suspended cells. RT-PCR was used for observation of MAb mRNA expression and a two-color bromode-oxyuridine (BrdU)/propidium iodide (PI) flow cytometry method for determination of cell cycle distribution. The results revealed that MAb mRNA expression reached the peak during the exponential growth phase, suggest a positively growth-associated MAb production. And the immobilized cells continued the MAb mRNA expression until dead phase, which was longer than that in suspended cells. The cell cycle distribution patterns were observed almost the same for both immobilized and suspended cells. Such results may imply that a high cell density state has positive influence on the mRNA expression and on growth-associated MAb productivity of T0405 cells.

[1]  G. Moore,et al.  Immunoglobulin production in synchronized cultures of human hematopoietic cell lines. I. Variation of cellular immunoglobulin level with the generation cycle. , 1969, Journal of immunology.

[2]  J. Gray,et al.  Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Thakur,et al.  Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains , 1993, The Journal of experimental medicine.

[4]  D R Burton,et al.  Human combinatorial antibody libraries to hepatitis B surface antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Kargı,et al.  Coiled tube membrane bioreactor for cultivation of hybridoma cells producing monoclonal antibodies. , 1990, Enzyme and Microbial Technology.

[6]  H. Kataoka,et al.  Kinetic study on HBs-MAb production in continuous cultivation. , 1994, Journal of biotechnology.

[7]  K. Hashimoto,et al.  Growth Yields of Hybridoma Cells and Monoclonal Antibody Production in High Density Culture , 1993 .

[8]  M. Flickinger,et al.  A structured model for monoclonal antibody synthesis in exponentially growing and stationary phase hybridoma cells , 1991, Biotechnology and bioengineering.

[9]  J. Barford,et al.  A study of hybridoma cell growth and antibody production kinetics in continuous culture , 1987 .

[10]  C. Shearman,et al.  [Construction, expression and characterization of a murine/human chimeric antibody with specificity for hepatitis B surface antigen]. , 1990, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.

[11]  P. Hudson,et al.  Construction of recombinant extended single-chain antibody peptide conjugates for use in the diagnosis of HIV-1 and HIV-2. , 1996, Journal of immunological methods.

[12]  C. Milstein,et al.  Stability of cytoplasmic ribonucleic acid in a mouse myeloma: estimation of the half-life of the messenger RNA coding for an immunoglobulin light chain. , 1974, Journal of molecular biology.

[13]  L. Aarden Hybridoma Growth Factor , 1989, Annals of the New York Academy of Sciences.

[14]  B. Palsson,et al.  Cell Culture conditions determine the enhancement of specific monoclonal antibody productivity of calcium alginate‐entrapped S3H5/γ2bA2 hybridoma cells , 1993, Biotechnology and bioengineering.

[15]  C. Ryu,et al.  Cloning and sequence analysis of cDNAs encoding the heavy and light chain variable regions of a human monoclonal antibody with specificity for hepatitis B surface antigen. , 1998, Biochimica et biophysica acta.

[16]  R. Spier,et al.  Kinetics of Cell Metabolism and Antibody Production in High Concentration Perfusion Cultures , 1993 .

[17]  S. Ozturk,et al.  Medium Optimization for Perfused Culture to Provide High Product Titer , 1993 .

[18]  G. Belfort,et al.  Manipulation of Heterogeneous Hybridoma Cultures for Overproduction of Monoclonal Antibodies , 1991, Biotechnology progress.

[19]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[20]  A. L. Wezel Growth of Cell-strains and Primary Cells on Micro-carriers in Homogeneous Culture , 1967, Nature.

[21]  W M Miller,et al.  A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: Effect of nutrient concentration, dilution rate, and pH , 2000, Biotechnology and bioengineering.

[22]  B. Palsson,et al.  Immobilization can improve the stability of hybridoma antibody productivity in serum‐free media , 1990, Biotechnology and bioengineering.

[23]  T. Lindmo,et al.  Flow cytometry and sorting , 1979 .

[24]  R. Pörtner,et al.  Physiological Status of Immobilized Hybridoma Cells: Assessment through Extracellular DNA Analysis , 1997 .

[25]  Nicolas Kalogerakis,et al.  The effect of specific growth rate and death rate on monoclonal antibody production in hybridoma chemostat cultures , 1991 .

[26]  Amit Varma,et al.  Production of monoclonal antibody using free‐suspended and immobilized hybridoma cells: Effect of serum , 1991, Biotechnology and bioengineering.

[27]  A. Kim,et al.  Cloning and characterization of cDNAs coding for heavy and light chains of a monoclonal antibody specific for pre-S2 antigen of hepatitis B virus. , 1992, Gene.

[28]  O. Merten,et al.  Kinetic studies of cellular metabolic activity, specific IgG production rate, IgG mRNA stability and accumulation during hybridoma batch culture. , 1992, Enzyme and microbial technology.

[29]  D. Robinson,et al.  Kinetics of recombinant immunoglobulin production by mammalian cells in continuous culture , 1991, Biotechnology and bioengineering.

[30]  R. Spier,et al.  Relationship between hybridoma growth and monoclonal antibody production. , 1992, Enzyme and microbial technology.

[31]  C. Ryu,et al.  Cloning, expression and characterization of a murine-human chimeric antibody with specificity for pre-S2 surface antigen of hepatitis B virus. , 1993, Molecular immunology.

[32]  H. Kataoka,et al.  HBs-MAb production in perfusion culture with selective ammonia removal system. , 1994, Journal of biotechnology.